Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Juni 2020 02:00 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC starts its accelerated COVID-19 Phase 2 clinical trial of OmeGo® salmon oil to decrease Acute Respiratory Distress Syndrome and the need for assisted respiration

Reference is made to the stock exchange notice on 26 May 2020 and Hofseth BioCare ASA (“HBC”) announces that Health Canada has approved its accelerated phase 2 investigational trial protocol of CARDIO...
26. Mai 2020 02:00 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC har startet protokollutvikling for en akselerert klinisk fase 2-studie med OmeGo® for å redusere akutt lungesvikt og behovet for kunstig åndedrett hos COVID-19 pasienter

Hofseth BioCare ASA (“HBC”) forbereder en protokoll med KGK Science til Health Canada for å gjennomføre en fase 2 klinisk studie som skal vurdere OmeGo® i form av HBCs ferdigprodukt CARDIO...
26. Mai 2020 02:00 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC has begun protocol development for its accelerated Phase 2 clinical trial with OmeGo® to decrease Acute Respiratory Distress Syndrome and the need for assisted respiration in COVID-19 patients

Hofseth BioCare ASA (“HBC”) is preparing an investigational protocol with KGK Science into Health Canada to conduct a Phase 2 clinical trial assessing OmeGo® in the form of our branded product CARDIO...
25. Mai 2020 05:55 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: Completed Annual General Meeting

The AGM in Hofseth BioCare ASA were held in Havnegata 11, Ålesund today on Monday 25 May 2020. All the matters were decided according to the proposals in the notice. Please find the minutes from the...
22. Mai 2020 06:26 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA:

Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 ...
22. Mai 2020 06:26 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: Proxy Rights at Annual General Meeting

Ola Holen, Chairman of the Board of Hofseth BioCare ASA, has in connection to the upcoming Annual General Meeting on 25 May 2020, received proxy rights from shareholders representing 158 596 305...
15. Mai 2020 02:00 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: Preclinical research with OmeGo® demonstrates potential to treat eosinophilic asthma

Hofseth BioCare ASA (“HBC”) recently filed a US patent application (630063274 04/07/2020) on minor components in OmeGo® salmon oil that significantly attenuate respiratory eosinophilic inflammation,...
15. Mai 2020 02:00 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: First Quarter 2020 Financial Report

HBC had operating revenues of NOK 18.5m (NOK 14.7m) in the first quarter of 2020. Cost of Goods Sold (CoGS) amounted to NOK 6.2m (NOK 10.9m) in the period. Operational profit (EBITDA) for the first...
11. Mai 2020 01:55 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: Two-year research collaboration contract signed with Stanford on the use of Salmon Protein Hydrolysate peptides for the treatment of GI tract diseases in children and adults

Hofseth BioCare ASA (“HBC”) has signed a two-year research agreement with Stanford University School of Medicine, CA, USA to further investigate the gastro-intestinal (GI)-protective properties of...
04. Mai 2020 11:26 ET | Quelle: Hofseth Biocare ASA

Hofseth Biocare ASA: Notice of Annual General Meeting 2020

The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Havnegata 11, 6005 Ålesund, on 25 May 2020 at 11:00 CET. All shareholders are encouraged to submit a voting...

Vorherige Seite

Nächste Seite